5. Shadle PJ. Qualification of raw materials for biopharmaceutical use. BioPharm Int. 2004; 2:28–41. 6. Ritter N, et al. What is test method qualification? Proceedings of the WCBP Strategy Forum. 2003 Jul 24. Gaithersburg,
MD. 7. ICH. Q2(R1), Validation of analytical procedures: text and methodology. Geneva, Switzerland; 2005. 8. Brunkow R, et al. Cleaning and cleaning validation: a biotechnology perspective. Bethesda, MD: Parenteral Drug Association;
1995. 9. Hall W. Validation and verification of cleaning processes. In: Nash R, Wachter A. editors. Pharmaceutical process validation.
New York: Informa Health Care; 2003. p. 465–506. 10. The Automotive Division of the American Society for Quality (ASQC) and the Automotive Industry Action Group (AIAG). Potential
failure mode and effects analysis, FMEA. 1995 Feb. Southfield, MI: AIAG. 11. Montgomery DC. Design and Analysis of Experiments, 4th ed. New York: John Wiley & Sons, Inc.; 1997. 12. Parenteral Drug Association. PDA technical report no. 42: Process validation of protein manufacturing. Bethesda, MD:
PDA; 2005. 13. US Food and Drug Administration. Guidance for industry. Guidelines on general principles of process validation. Rockville,
MD; 1987. 14. Ferenc BM. Qualification and change control in validation of pharmaceutical processes, 2nd ed.; Carleton F, Agalloco
J. editors. New York: Marcell Dekker, Inc.; 1999; p. 132–150. 15. The Automotive Division of the American Society for Quality (ASQC) and the Automotive Industry Action Group (AIAG). Statistical
process control (SPC) reference manual; 1995 Mar. Southfield, MI: AIAG.
| 
